Innovative Pharmaceutical Biotech Equity 2024

Innovative Pharmaceutical Biotech Aktienanalyse

What does Innovative Pharmaceutical Biotech do?

The company Innovative Pharmaceutical Biotech Ltd is a company that is active in the field of biotechnological and pharmaceutical research and development. The company has its roots in the research and development of innovative active substances and drugs. The company's history began in the 1990s, when a group of scientists came together to bundle their expertise and visions and develop innovative solutions in the field of active substance research. They founded Innovative Pharmaceutical Biotech Ltd as an independent company in 2000. The company's business model is based on the research and development of new active substances and drugs in the field of oncology, neurology, and immunology. The company follows an insistence-driven approach, aiming to develop active substances with innovative mechanisms of action that are superior to proven therapeutic approaches. Innovative Pharmaceutical Biotech Ltd collaborates with a broad network of partners and cooperation partners, including academic research institutions, clinical centers, biotech companies, and pharmaceutical companies. The company cooperates with companies from all over the world and operates worldwide. The company has various divisions, each focusing on the development of active substances and drugs in specific medical fields. In the oncology division, the company develops active substances and drugs for the treatment of cancer. In the neurology division, active substances and drugs for the treatment of neurological diseases such as Alzheimer's and Parkinson's are researched and developed. The immunology division of the company is dedicated to the development of active substances and drugs for the treatment of immune system diseases such as autoimmune diseases and inflammations. Over the years, the company has developed and launched a number of products. One of its most important products is an active substance for the treatment of breast cancer, which has shown promising results in clinical studies. The company has also developed a treatment for the relief of pain in cancer and other patients based on chemotherapy symptoms. In addition to its research and development efforts, Innovative Pharmaceutical Biotech Ltd attaches great importance to compliance with standards and regulations in the pharmaceutical and biotechnological industry. The company maintains strict quality control procedures and strives to adhere to the highest standards in drug manufacturing. Innovative Pharmaceutical Biotech Ltd sees itself as a pioneer in the pharmaceutical and biotechnological industry and takes pride in developing innovative solutions that have the potential to improve the lives of people around the world. The company has a variety of partners and cooperation partners worldwide and is proud to have a global presence in the field of biotechnological and pharmaceutical research and development. In summary, Innovative Pharmaceutical Biotech Ltd is a company that focuses on the research and development of innovative active substances and drugs that have the potential to improve the lives of people worldwide. The company collaborates with a broad network of partners and cooperation partners and maintains strict quality control procedures to adhere to the highest standards in drug manufacturing. The translation is as accurate as possible. Innovative Pharmaceutical Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Innovative Pharmaceutical Biotech's Equity

Innovative Pharmaceutical Biotech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Innovative Pharmaceutical Biotech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Innovative Pharmaceutical Biotech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Innovative Pharmaceutical Biotech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Innovative Pharmaceutical Biotech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Innovative Pharmaceutical Biotech stock

What is the equity of Innovative Pharmaceutical Biotech this year?

Innovative Pharmaceutical Biotech has equity of -611.51 M HKD this year.

What was the equity of Innovative Pharmaceutical Biotech compared to the previous year?

The equity of Innovative Pharmaceutical Biotech has increased/decreased by 11.31% increased compared to the previous year.

What impact does a high equity have on investors of Innovative Pharmaceutical Biotech?

A high equity is advantageous for investors of Innovative Pharmaceutical Biotech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Innovative Pharmaceutical Biotech?

A low equity can be a risk for investors of Innovative Pharmaceutical Biotech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Innovative Pharmaceutical Biotech affect the company?

An increase in equity of Innovative Pharmaceutical Biotech can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Innovative Pharmaceutical Biotech affect the company?

A reduction in equity of Innovative Pharmaceutical Biotech can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Innovative Pharmaceutical Biotech?

Some factors that can affect the equity of Innovative Pharmaceutical Biotech include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Innovative Pharmaceutical Biotech so important for investors?

The equity of Innovative Pharmaceutical Biotech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Innovative Pharmaceutical Biotech take to change the equity?

To change equity, Innovative Pharmaceutical Biotech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Innovative Pharmaceutical Biotech pay?

Over the past 12 months, Innovative Pharmaceutical Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovative Pharmaceutical Biotech is expected to pay a dividend of 0 HKD.

What is the dividend yield of Innovative Pharmaceutical Biotech?

The current dividend yield of Innovative Pharmaceutical Biotech is .

When does Innovative Pharmaceutical Biotech pay dividends?

Innovative Pharmaceutical Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innovative Pharmaceutical Biotech?

Innovative Pharmaceutical Biotech paid dividends every year for the past 0 years.

What is the dividend of Innovative Pharmaceutical Biotech?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innovative Pharmaceutical Biotech located?

Innovative Pharmaceutical Biotech is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Innovative Pharmaceutical Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innovative Pharmaceutical Biotech from 12/31/2003 amounting to 0.02 HKD, you needed to have the stock in your portfolio before the ex-date on 12/10/2003.

When did Innovative Pharmaceutical Biotech pay the last dividend?

The last dividend was paid out on 12/31/2003.

What was the dividend of Innovative Pharmaceutical Biotech in the year 2023?

In the year 2023, Innovative Pharmaceutical Biotech distributed 0 HKD as dividends.

In which currency does Innovative Pharmaceutical Biotech pay out the dividend?

The dividends of Innovative Pharmaceutical Biotech are distributed in HKD.